TMRW Life Sciences, Inc. — Form D/A

TMRW Life Sciences, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2022-05-13. The offering totals $102.2M, of which $100.2M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Tara ComonteDirectorNew York, NY
Emily ConleyDirectorBerkeley, CA
Alan MurrayDirectorIrving, TX
Roberta MyersDirectorNew York, NY
Jeffrey PortDirectorNew York, NY
Andrew SchwabDirectorBOSTON, MA
Vinay ShahDirectorNew York, NY
Tara ComonteExecutive OfficerNew York, NY
MELANIE GOLDEYExecutive OfficerNEW YORK, NY
Andrew SchwabRelated PersonBOSTON, MA
Vinay ShahRelated PersonNew York, NY
Joshua AbramDirectorNew York, NY
Andrew Drabant SchwabDirectorNew York, NY
Vinay Drabant ShahDirectorNew York, NY
Roberta Drabant MyersDirectorNew York, NY
Alan Drabant MurrayDirectorNew York, NY
Emily Drabant ConleyDirectorNew York, NY
Louis Drabant VillabaDirectorNew York, NY
Jeffrey Drabant PortDirectorNew York, NY
Jeffrey PortRelated PersonNew York, NY
Louis VillalbaRelated PersonNew York, NY
William SchoolcraftRelated PersonNew York, NY
Greg EisnerRelated PersonNew York, NY
Emily Drabant ConleyRelated PersonNew York, NY

Other filings by this issuer (6)

FiledFormOfferingSold
2026-04-24D$38.4M$38.4M
2024-07-12D$30.0M$28.2M
2021-07-15D$80.2M$80.2M
2021-02-12D$20.0M$20.0M
2020-05-19D/A$36.5M$36.5M
2019-12-23D$29.0M$29.0M

More